Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Clinical Oncology

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000421-199806000-00025PMID 9626808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ifosfamide in sarcomas: is it a schedule-dependent drug?

  1996cited by this paper
• Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

  1995cited by this paper
• Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

  1993cited by this paper
• Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.

  1993cited by this paper
• An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

  1993cited by this paper
• Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

  1989cited by this paper
• Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials Group.

  1989cited by this paper
• Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

  1989cited by this paper
• Dose response evaluation of adriamycin in human neoplasia

  1977cited by this paper

• Real‐World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort

  2026cites this paper
• A Comprehensive Review of Chemotherapy in Localized Soft Tissue Sarcomas: Is the Cat Out of the Bag Yet?

  2025cites this paper
• Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma

  2025cites this paper
• 5‐fluoro‐deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long‐term outcomes in soft tissue sarcomas: Results from a prospective trial

  2025cites this paper
• Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma

  2025cites this paper
• Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology

  2024cites this paper
• Soft Tissue Sarcomas in Adolescents and Young Adults.

  2023cites this paper
• A Rare Case of Primary Mesenteric Liposarcoma

  2023cites this paper
• Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo

  2022cites this paper
• A case report of a primary pericardial leiomyosarcoma: An extremely rare cardiac neoplasm

  2022cites this paper
• 33 Sarcomas of the Skull Base Sarcomas of the skull base

  2021cites this paper
• Sarcoma of the Breast: Clinical Characteristics and Outcomes of 991 Patients from the National Cancer Database

  2021cites this paper
• Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile

  2021cites this paper
• Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas

  2020cites this paper
• Complete remission of a case of high-grade myxofibrosarcoma with lung metastases after modified MAID regimen chemotherapy

  2020cites this paper
• Individualisierte multimodale Therapie retroperitonealer Weichteilsarkome

  2020cites this paper
• Pediatric Solid Tumors

  2020cites this paper
• Sarcomas of Soft Tissue

  2020cites this paper
• How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centers

  2019cites this paper
• Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy

  2019cites this paper
• Synchronous Primary Leiomyosarcoma in the Thoracic Vertebra and the Liver

  2019cites this paper
• Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial

  2019cites this paper
• Angiosarcoma — a malignant neoplasm secondary to radiotherapy for breast cancer in a female patient following breast-conserving treatment — a case report

  2019cites this paper
• Head and Neck Tumors: Management of Primary Undifferentiated Pleomorphic Sarcoma.

  2019cites this paper
• The challenge of the management of adolescents and young adults with soft tissue sarcomas

  2018cites this paper
• Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts.

  2017cites this paper
• Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.

  2017cites this paper
• Targeted therapy for soft tissue sarcomas in adolescents and young adults

  2017cites this paper
• Immunotherapies in sarcoma: Updates and future perspectives

  2017cites this paper
• Chemotherapy and Other Systemic Approaches to Adult Sarcomas

  2017cites this paper
• Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.

  2016cites this paper
• eutropenia inducida por quimioterapia : el punto e vista del oncólogo edro de

  2016cites this paper
• Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

  2016cites this paper
• Chemotherapy for soft tissue sarcoma

  2016cites this paper
• Major clinical research advances in gynecologic cancer in 2015

  2016cites this paper
• Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services

  2016cites this paper
• Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.

  2016cites this paper
• Proteogenomics for the Study of Gastrointestinal Stromal Tumors.

  2016cites this paper
• Primary pulmonary chondrosarcoma and a fast-growing mass that accidentally mimicked teratoma.

  2016cites this paper
• Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report

  2016cites this paper
• Neutropenia inducida por quimioterapia: el punto de vista del oncólogo

  2016cites this paper
• Update on clinical research and state of the art management of patients with advanced sarcomas and GIST

  2016cites this paper
• Systemic Therapy for Advanced Soft Tissue Sarcoma.

  2016cites this paper
• Chemotherapy for Bone Sarcoma in Adults.

  2016cites this paper
• First-line treatment in advanced or metastatic disease: one size fits all or adapted to specific histiotypes?

  2016cites this paper
• Recurrent Primaty Adrenal Leiopyosarcoma: A Complete Literature Review and Presentation of a Rare Adrenal Tumor

  2015cites this paper
• A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma

  2015cites this paper
• Chemotherapy for bone sarcomas in adults: the MD anderson experience.

  2015cites this paper
• Chemotherapy for soft-tissue sarcomas.

  2015cites this paper
• Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas.

  2015cites this paper
• Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia

  2015cites this paper
• Soft Tissue Sarcomas

  2015cites this paper
• Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma

  2015cites this paper
• Management of extremity malignant fibrous histiocytoma: A 10-year experience

  2015cites this paper
• Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial.

  2015cites this paper
• High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma

  2014cites this paper
• Targeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis.

  2014cites this paper
• One step forward, two steps back.

  2014cites this paper
• Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

  2014cites this paper
• New and emerging therapies for advanced or metastatic soft tissue sarcoma

  2014cites this paper
• Sarcomas of Soft Tissue

  2014cites this paper
• Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.

  2014cites this paper
• The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.

  2013cites this paper
• Systemic Therapy, Radiotherapy, and Cardiotoxicity

  2013cites this paper
• Multimodality therapy for advanced or metastatic sarcoma.

  2013cites this paper
• Systemic Therapy in Sarcomas: Integrating the Old with the New CHAIR

  2013cites this paper
• Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

  2013cites this paper
• Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

  2013cites this paper
• Biotargets in Sarcomas: The Past, Present, and a Look into the Future

  2012cites this paper
• Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer: A Randomized Trial

  2012cites this paper
• Recent Developments in Salvage Chemotherapy for Patients with Metastatic Soft Tissue Sarcoma

  2012cites this paper
• Cellular immunotherapy for soft tissue sarcomas.

  2012cites this paper
• Identifying and Targeting Molecular Deregulations in Uterine Leiomyosarcoma: A Role for mTOR Inhibition-Based Combination Therapies

  2012cites this paper
• Prognostic Significance of Elevated D-Dimer for Survival in Patients with Sarcoma

  2012cites this paper
• Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma

  2012cites this paper
• Primary Pericardial Sarcoma: A Case Report and a Brief Review

  2011cites this paper
• Is Radical Oncosurgery Justified for the Treatment of Primary Malignant Fibrous Histiocytoma of the Urinary Bladder? Report of Two Cases and Analyses of Disease-Specific Survival Rates Based on a Review of the Literature

  2011cites this paper
• Primary synovial sarcoma of pericardium: A case report

  2011cites this paper
• Systemic Management Strategies for Metastatic Soft Tissue Sarcoma

  2011cites this paper
• 腫 ( Malignant Fibrous Histiocytoma : MFH ) の 一 手 術 例 小川 伸郎 , 栗栖 純穂 , 阿部 能明 , 矢野 真 , 森田 敬知 稲垣 敬三 , 荒井他嘉司 , 田島 洋 *

  2011cites this paper
• Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

  2011cites this paper
• The effects of omega-3 fatty acids in an ovine model of anthracycline-induced non-ischaemic cardiomyopathy.

  2011cites this paper
• Prolonged 14‐day continuous infusion of high‐dose ifosfamide with an external portable pump: Feasibility and efficacy in refractory pediatric sarcoma

  2010cites this paper
• Systemic therapy for cardiac sarcomas.

  2010cites this paper
• Histology-driven chemotherapy of soft-tissue sarcoma.

  2010cites this paper
• Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer

  2010cites this paper
• Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas

  2010cites this paper
• Diagnosis and management of primary breast sarcoma

  2010cites this paper
• Soft tissue sarcoma.

  2010cites this paper
• Cisplatino y doxorrubicina en sarcomas avanzados de partes blandas: esquema de primera línea Cisplatin plus doxorubicine in advanced soft tissue sarcoma: first line chemotherapy

  2009cites this paper
• Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.

  2009cites this paper
• Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.

  2009cites this paper
• Nonrhabdomyosarcomas and Other Soft Tissue Tumors

  2009cites this paper
• Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways.

  2009cites this paper
• 背部に生じたundifferentiated high－grade pleomorphic sarcoma（so－called“MFH”）の2例

  2009cites this paper
• Pediatric nonrhabdomyosarcoma soft tissue sarcomas.

  2008cites this paper
• Targeted Therapy of Sarcoma

  2008cites this paper
• Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma

  2008cites this paper
• Primary high-grade myofibroblastic sarcoma arising from the pericardium.

  2008cites this paper
• Overview of thrombopoietic agents in the treatment of thrombocytopenia.

  2008cites this paper